Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

2,361 public trials 354 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis

NCT01156311

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Danbury, Connecticut, United States
  • Research Site Atlanta, Georgia, United States
View all 16 locations
View Trial Details
Completed

Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms

NCT01333501

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
Locations
  • Novartis Investigative Site Alzenau in Unterfranken, Germany
  • Novartis Investigative Site Bamberg, Germany
  • Novartis Investigative Site Leipzig, Germany
  • Novartis Investigative Site Würzburg, Germany
View all 26 locations
View Trial Details
Completed

Natalizumab Re-Initiation of Dosing

NCT00306592

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Scottsdale, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
View all 63 locations
View Trial Details
Completed

Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis

NCT00622700

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +8 more
Locations
  • Investigational Site Number 8965 Cullman, Alabama, United States
  • Investigational Site Number 8954 Phoenix, Arizona, United States
  • Investigational Site Number 8946 Phoenix, Arizona, United States
  • Investigational Site Number 8962 Fort Collins, Colorado, United States
View all 131 locations
View Trial Details

Related conditions